Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Operating Income 2010-2024 | MKGAF

Merck annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Merck operating income for the quarter ending June 30, 2024 was $0.854B, a 19.26% decline year-over-year.
  • Merck operating income for the twelve months ending June 30, 2024 was $3.603B, a 16.53% decline year-over-year.
  • Merck annual operating income for 2023 was $3.907B, a 17.11% decline from 2022.
  • Merck annual operating income for 2022 was $4.714B, a 4.64% decline from 2021.
  • Merck annual operating income for 2021 was $4.943B, a 44.97% increase from 2020.
  
Merck Annual Operating Income
(Millions of US $)
2023 $3,907
2022 $4,714
2021 $4,943
2020 $3,410
2019 $2,374
2018 $2,038
2017 $2,854
2016 $2,747
2015 $2,045
2014 $2,342
2013 $2,893
2012 $1,984
2011 $1,555
2010 $12,338
2009 $10,807
Merck Quarterly Operating Income
(Millions of US $)
2024-06-30 $854
2024-03-31 $1,011
2023-12-31 $667
2023-09-30 $1,071
2023-06-30 $1,058
2023-03-31 $1,111
2022-12-31 $904
2022-09-30 $1,244
2022-06-30 $1,249
2022-03-31 $1,316
2021-12-31 $1,186
2021-09-30 $1,236
2021-06-30 $1,264
2021-03-31 $1,257
2020-12-31 $716
2020-09-30 $1,363
2020-06-30 $541
2020-03-31 $790
2019-12-31 $572
2019-09-30 $678
2019-06-30 $695
2019-03-31 $429
2018-12-31 $361
2018-09-30 $571
2018-06-30 $469
2018-03-31 $638
2017-12-31 $301
2017-09-30 $1,058
2017-06-30 $691
2017-03-31 $805
2016-12-31 $433
2016-09-30 $754
2016-06-30 $622
2016-03-31 $937
2015-12-31 $329
2015-09-30 $644
2015-06-30 $554
2015-03-31 $573
2014-12-31 $112
2014-09-30 $569
2014-06-30 $504
2014-03-31 $644
2013-12-31 $539
2013-09-30 $830
2013-06-30 $870
2013-03-31 $643
2012-12-31 $3,646
2012-09-30 $601
2012-06-30 $79
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $151
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $618
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $23.031B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $88.286B 35.17
Takeda Pharmaceutical (TAK) Japan $46.614B 9.33
Astellas Pharma (ALPMY) Japan $21.569B 25.91
Sandoz Group AG (SDZNY) Switzerland $18.132B 0.00
Summit Therapeutics (SMMT) United States $16.527B 0.00
United Therapeutics (UTHR) United States $15.915B 16.44
Shionogi (SGIOY) Japan $13.333B 12.77
Neurocrine Biosciences (NBIX) United States $11.706B 35.02
Catalent (CTLT) United States $10.940B 0.00
Orion OYJ (ORINY) Finland $7.664B 31.21
Revolution Medicines (RVMD) United States $7.326B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.805B 7.22
Ionis Pharmaceuticals (IONS) United States $6.009B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.644B 0.00
Corcept Therapeutics (CORT) United States $4.522B 38.30
Crinetics Pharmaceuticals (CRNX) United States $4.048B 0.00
Dyne Therapeutics (DYN) United States $3.476B 0.00
PTC Therapeutics (PTCT) United States $2.897B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.585B 14.91
Arrowhead Pharmaceuticals (ARWR) United States $2.439B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.368B 18.82
Recursion Pharmaceuticals (RXRX) United States $2.016B 0.00
Soleno Therapeutics (SLNO) United States $1.896B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.776B 0.00
Xencor (XNCR) United States $1.595B 0.00
Harrow (HROW) United States $1.569B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.568B 0.00
Cassava Sciences (SAVA) United States $1.529B 0.00
Ardelyx (ARDX) United States $1.497B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.425B 0.00
ARS Pharmaceuticals (SPRY) United States $1.407B 0.00
Ocular Therapeutix (OCUL) United States $1.369B 0.00
Indivior (INDV) United States $1.368B 6.28
Collegium Pharmaceutical (COLL) United States $1.239B 7.11
Evotec AG (EVO) Germany $1.237B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.213B 0.00
Enliven Therapeutics (ELVN) United States $1.139B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.024B 0.00
Relay Therapeutics (RLAY) United States $0.991B 0.00
Bioventus (BVS) United States $0.895B 29.08
Cronos Group (CRON) Canada $0.837B 0.00
USANA Health Sciences (USNA) United States $0.721B 13.23
Savara (SVRA) United States $0.698B 0.00
Pacira BioSciences (PCRX) United States $0.661B 6.26
Ironwood Pharmaceuticals (IRWD) United States $0.649B 40.60
Exscientia (EXAI) United Kingdom $0.641B 0.00
Tourmaline Bio (TRML) United States $0.637B 0.00
ProKidney (PROK) United States $0.591B 0.00
4D Molecular Therapeutics (FDMT) United States $0.570B 0.00
Foghorn Therapeutics (FHTX) United States $0.536B 0.00
Silence Therapeutics (SLN) United Kingdom $0.522B 0.00
OmniAb (OABI) United States $0.500B 0.00
Siga Technologies (SIGA) United States $0.495B 5.93
Altimmune (ALT) United States $0.484B 0.00
Aquestive Therapeutics (AQST) United States $0.455B 0.00
Sage Therapeutics (SAGE) United States $0.438B 0.00
KalVista Pharmaceuticals (KALV) United States $0.432B 0.00
Xeris Biopharma Holdings (XERS) United States $0.422B 0.00
Verve Therapeutics (VERV) United States $0.420B 0.00
Elite Pharmaceuticals (ELTP) United States $0.416B 38.90
Larimar Therapeutics (LRMR) United States $0.404B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.394B 0.00
Lyell Immunopharma (LYEL) United States $0.389B 0.00
Zevra Therapeutics (ZVRA) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.374B 0.00
Eliem Therapeutics (ELYM) United States $0.335B 0.00
Korro Bio (KRRO) United States $0.323B 0.00
Esperion Therapeutics (ESPR) United States $0.322B 0.00
Aldeyra Therapeutics (ALDX) United States $0.319B 0.00
Heron Therapeutics (HRTX) United States $0.311B 0.00
Lexeo Therapeutics (LXEO) United States $0.295B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.282B 0.00
Akebia Therapeutics (AKBA) United States $0.280B 0.00
ESSA Pharma (EPIX) Canada $0.276B 0.00
Avita Medical (RCEL) United States $0.275B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.259B 0.00
Nature's Sunshine Products (NATR) United States $0.250B 17.11
Black Diamond Therapeutics (BDTX) United States $0.249B 0.00
Nanobiotix S.A (NBTX) France $0.233B 0.00
Acrivon Therapeutics (ACRV) United States $0.225B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.222B 0.00
Pyxis Oncology (PYXS) United States $0.221B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.218B 0.00
Nektar Therapeutics (NKTR) United States $0.204B 0.00
CytoDyn (CYDY) United States $0.193B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
Telomir Pharmaceuticals (TELO) United States $0.191B 0.00
MediWound (MDWD) Israel $0.180B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Galectin Therapeutics (GALT) United States $0.165B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
Cardiol Therapeutics (CRDL) Canada $0.148B 0.00
VAXART, INC (VXRT) United States $0.143B 0.00
Context Therapeutics (CNTX) United States $0.139B 0.00
Century Therapeutics (IPSC) United States $0.130B 0.00
Incannex Healthcare (IXHL) Australia $0.130B 0.00
Prelude Therapeutics (PRLD) United States $0.122B 0.00
Fractyl Health (GUTS) United States $0.121B 0.00
Assertio Holdings (ASRT) United States $0.116B 20.33
Journey Medical (DERM) United States $0.113B 0.00
Regulus Therapeutics (RGLS) United States $0.103B 0.00
OptiNose (OPTN) United States $0.103B 0.00
Relmada Therapeutics (RLMD) United States $0.099B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.095B 0.00
Citius Pharmaceuticals (CTXR) United States $0.093B 0.00
AlloVir (ALVR) United States $0.090B 0.00
CASI Pharmaceuticals (CASI) China $0.089B 0.00
Karyopharm Therapeutics (KPTI) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Metagenomi (MGX) United States $0.076B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 370.33
Verrica Pharmaceuticals (VRCA) United States $0.072B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
Mural Oncology (MURA) Ireland $0.052B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
ProPhase Labs (PRPH) United States $0.043B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Carisma Therapeutics (CARM) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Inotiv (NOTV) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
DURECT (DRRX) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
Protara Therapeutics (TARA) United States $0.038B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.033B 0.00
Oruka Therapeutics (ORKA) United States $0.029B 0.00
VYNE Therapeutics (VYNE) United States $0.028B 0.00
Lipocine (LPCN) United States $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
MEI Pharma (MEIP) United States $0.019B 0.67
TherapeuticsMD (TXMD) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.019B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Talphera (TLPH) United States $0.014B 0.00
Conduit Pharmaceuticals (CDT) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.011B 0.00
Vivos Therapeutics (VVOS) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
BioVie (BIVI) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.09
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 38.56